title: Budget Impact Analysis to Estimate the Cost Dynamics of Treating Refractory Gastroesophageal Reflux Disease With Radiofrequency Energy: a Payer Perspective.
abstract: OBJECTIVE
  A minimally invasive endoscopic treatment that utilizes radio-frequency energy (RFE) has received increased attention as an appropriate middle-ground approach in the treatment of refractory gastroesophageal reflux disease (GERD) and as an alternative to complicated and invasive surgical procedures. The objective of this study was to develop a longitudinal budget impact analysis from the payer perspective to estimate the direct medical costs of treatment for the refractory GERD patient population and to estimate the budgetary impact of further extending the RFE treatment option to other target populations.
  
  
  METHODS
  A retrospective analysis of claims designed to assess the longitudinal costs and budget impact on payer expenditures associated with managing and treating GERD surgically (Nissen fundoplication [NF]), endoscopically (RFE), or medically was performed. Both Medicare and commercially insured claims databases were interrogated for such population-level analyses.
  
  
  RESULTS
  At current adoption rates (less than 1% of procedures), RFE demonstrated overall cost savings ranging from 7.3% to 50.5% in the 12-month time period following the index procedure (inclusive of procedure costs) when compared to medical management and fundoplication across the commercial and Medicare patient populations. Increasing the total number of RFE procedures to 2% of total cases performed generated per-member, per-month (PMPM) savings of $0.28 in the Medicare population and $0.37 in the commercially insured population. Further increases yielded higher PMPM savings.
  
  
  CONCLUSIONS
  Adding to the clinical importance of RFE in filling the gap between medical and surgical management, this economic analysis demonstrates to payers that the adoption of RFE can create notable savings to their plans when compared to surgery or medical management.
authors.forename: David
authors.initials: D
authors.lastname: Gregory
authors.forename: Dennis J
authors.initials: DJ
authors.lastname: Scotti
authors.forename: Daniel
authors.initials: D
authors.lastname: Buck
authors.forename: George
authors.initials: G
authors.lastname: Triadafilopoulos
mesh_terms: D002017:Budgets; D003365:Costs and Cost Analysis; D005764:Gastroesophageal Reflux / Q000532:radiotherapy*; D006801:Humans; D019458:Insurance Coverage / Q000191:economics; D006278:Medicare / Q000191:economics; D011878:Radiotherapy / Q000191:economics*; D012189:Retrospective Studies; D014481:United States